Ra Medical Systems Inc

Ra Medical Systems, Inc. engages in the design, development and commercialization of excimer lasers for the treatment of vascular immune-mediated inflammatory diseases. Its product, the Destruction of Arteriosclerotic Blockages by laser Radiation Ablation (DABRA) laser and single-use catheter, together referred to as DABRA, is used as a tool in the treatment of peripheral artery disease which commonly occurs in the legs. The company was founded by Dean Irwin and Melissa Burstein on September 4, 2002 and is headquartered in Carlsbad, CA.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Catheter Precision, Inc. engages in the design, manufacture and sale of medical devices and technologies for cardiac electrophysiology. It offers the Amigo Remote Catheter System for accurate positioning, manipulation, and stable control of catheters for use by electrophysiologists in the diagnosis and treatment of abnormal heart rhythms. The company was founded by David Jenkins in September 2002 and is headquartered in Fort Mill, SC.

FORT MILL, SC / ACCESSWIRE / February 10, 2023 / Ra Medical Systems (NYSE American:RMED) today announced the date of March 21, 2023 as the date of its special shareholder meeting. Shareholders of record as of February 3, 2023 are entitled to vote at the meeting.

Ra Medical Systems Announces Date of Special Shareholder Meeting

Catheter Precision Expands its VIVO™ Product into New Territories in the US FORT MILL, SC / ACCESSWIRE / February 1, 2023 / Ra Medical Systems, Inc. (NYSE American:RMED) (Ra Medical), a medical device and technology company focused on cardiac electrophysiology, announces that additional representatives have been hired to support its VIVO technology in new territories within the United States. VIVO, developed by Ra Medical's wholly owned subsidiary Catheter Precision, is a proprietary AI system used to non-invasively identify the origin of ventricular arrhythmias prior to an ablation procedure.

Ra Medical Systems Adds Additional Clinical and Sales Representatives

FORT MILL, S.C.--( BUSINESS WIRE )--Ra Medical Systems, Inc. (NYSE American: RMED) (Ra Medical), a medical device and technology company focused on cardiac electrophysiology, announces that four abstracts with clinical data supporting its VIVO technology have been accepted for presentation at the European Heart Rhythm Association Congress (EHRA 2023) being held April 16-18, 2023 in Barcelona. VIVO, developed by Ra Medical's wholly owned subsidiary Catheter Precision, is a proprietary AI system used to non-invasively identify the origin of ventricular arrhythmias prior to an ablation procedure.

Ra Medical Systems Announces the Presentation of Clinical Data at the European Heart Rhythm Association Congress

MT. OLIVE, N.J.--( BUSINESS WIRE )--Ra Medical Systems (NYSE American: RMED) announces a realignment of its board of directors in conjunction with the recently announced merger with Catheter Precision, Inc. David Jenkins has joined the board as Executive Chairman and James Caruso has been named director. Martin Colombatto, Will McGuire and Susann L. Meline will continue to serve as directors. Joan Stafslien and Richard Mejia, Jr. have resigned as directors, with board membership remaining at five.

Ra Medical Systems Realigns Its Board of Directors

MT. OLIVE, N.J. & CARLSBAD, Calif.--( BUSINESS WIRE )--Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”) announces the completion of its previously announced stock-for-stock merger transaction with Catheter Precision, Inc., a company focused on the cardiac electrophysiology market. Medtech veteran and Catheter Precision CEO and founder David Jenkins has joined Ra Medical's Board of Directors as Executive Chairman. Mr. Jenkins was instrumental in operating several medical device startups, including Transneuronix, Inc., which was acquired by Medtronic plc (NYSE: MDT) in July 2005, and EP MedSystems, Inc., which was acquired by St. Jude Medical (now owned by Abbott (NYSE: ABT)) in July 2008. James Caruso will also join the Board, to serve alongside continuing directors Martin Colombatto, Will McGuire and Susanne Meline.

Ra Medical Systems Completes Merger with Catheter Precision

CARLSBAD, Calif.--( BUSINESS WIRE )--Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”) announces that it has received notification from the NYSE American LLC (“NYSE American”) that the Company has regained compliance with the NYSE American's continued listing standard. Specifically, the Company has resolved the continued listing deficiency with respect to its low selling price as described in Section 1003(f)(v) of the NYSE American Company Guide.

Ra Medical Systems Regains Compliance with NYSE American Continued Listing Standards

MT. OLIVE, N.J. & CARLSBAD, Calif.--( BUSINESS WIRE )--Catheter Precision, Inc., a medical device and technology company focused on cardiac electrophysiology, announces that more than 800 procedures have been performed in a number of leading U.S. and European hospitals utilizing the VIVO System that enables physicians to noninvasively identify an area of ventricular arrhythmia onset. On September 12, 2022 privately held Catheter Precision announced a definitive merger agreement with Ra Medical Systems (NYSE American: RMED), which, if completed, will result in a combined publicly traded company focusing on the cardiac electrophysiology market.

Catheter Precision's VIVO™ System Used in More Than 800 Procedures in Leading U.S. and European Hospitals

MT. OLIVE, N.J. & CARLSBAD, Calif.--( BUSINESS WIRE )--Catheter Precision, Inc., a medical device and technology company focused on cardiac electrophysiology, announces the completion of more than 20 procedures at NYU Langone Hospital utilizing the VIVO System that enables physicians to identify the origin of arrhythmias pre-procedure. On September 12, 2022 privately held Catheter Precision announced a definitive merger agreement with Ra Medical Systems (NYSE American: RMED), which, if completed, will result in a combined publicly traded company focusing on the cardiac electrophysiology market.

Catheter Precision's VIVO™ Systems Used in More Than 20 Procedures at NYU Langone Hospital

CARLSBAD, Calif.--( BUSINESS WIRE )--Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”) reports financial results for the three and nine months ended September 30, 2022 and provides a business update.

Ra Medical Systems Reports Third Quarter 2022 Financial Results

Catheter Precision Expands U.S. Customer Base for VIVO™ for Non-invasive Arrythmia Location Detection Before Ventricular Ablation Procedures

Ra Medical (NYSEMKT: RMED ) stock is rocketing higher on Tuesday after the medical device company raised $7.6 million. This comes from an at-the-market (ATM) facility that saw the company sell 1,072,246 shares of RMED stock.

Why Is Ra Medical (RMED) Stock Up 25% Today?

Ra Medical Systems Raises $7.6 Million Through Completed At-The-Market Facility

Turquoise Hill Resources

NEW YORK , Oct. 5, 2022 /PRNewswire/ -- Juan Monteverde , founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating: iRobot Corp. (IRBT), relating to its proposed acquisition by Amazon.com, Inc. Under the terms of the agreement, IRBT shareholders are expected to receive $61.00 in cash per share they own. Click here for more information: https://www.monteverdelaw.com/case/irobot-corp.

SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger - IRBT, CYBE, TRQ, HIL, RMED

MT. OLIVE, N.J. & CARLSBAD, Calif.--(BUSINESS WIRE)--Catheter Precision, Inc. (“Catheter Precision”), a medical device company focused on cardiac electrophysiology, announces the filing of a new U.S. patent application for its VIVO™ (View Into Ventricular Onset) technology, as it continues its focus on patent protection for VIVO. On September 12, 2022 privately held Catheter Precision announced a definitive merger agreement with Ra Medical Systems (NYSE American: RMED), which, if completed, wil

Catheter Precision Files a Method-of-Use U.S. Patent Application for its VIVO™ Technology

MT. OLIVE, N.J. & CARLSBAD, Calif.--(BUSINESS WIRE)--Catheter Precision, Inc., a medical device and technology company focused on cardiac electrophysiology, announces that its lead product, VIVO™ (View Into Ventricular Onset), will be featured in presentations by three physicians working in the field of cardiac electrophysiology at the Sixth Annual Society of Cardiac Robotic Navigation (SCRN) meeting being held September 29-30 in Budapest, Hungary. On September 12, 2022 privately held Catheter

Catheter Precision's VIVO™ Technology to be Featured in Three Presentations at the Global Society of Cardiac Robotic Navigation Annual Meeting

Ambev

Transocean

Are these penny stocks worth buying right now? The post Why These ‘Must Watch' Penny Stocks Are Climbing Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Why These ‘Must Watch' Penny Stocks Are Climbing Right Now

MT. OLIVE, N.J. & CARLSBAD, Calif.--(BUSINESS WIRE)--Catheter Precision, Inc., a medical device and technology company focused on cardiac electrophysiology, announces the appointment of Fatih Ayoglu to the newly created position of Business Development Manager—EMEA. Mr. Ayoglu will oversee clinical and sales development of Catheter Precision products in Europe, the Middle East and Africa and will report to Chief Commercial Officer Patricia Kennedy. On September 12, 2022 privately held Catheter

Catheter Precision Names Fatih Ayoglu as Business Development Manager—EMEA

It's been an interesting day, to say the least. Investors of Ra Medical Systems (NYSEAMERICAN: RMED ) were exposed to massive volatility this morning.

Why Was Ra Medical Systems (RMED) Stock Up 20% Today?

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”) announces that at its virtual Special Meeting of Stockholders held today, the Company's stockholders approved all three proposals on the proxy filed with the Securities and Exchange Commission on August 29, 2022. The Company also announces that its Board of Directors has approved a 1-for-50 reverse stock split of the Company's common stock, with an effective time of 4:01 p.m. Easter

Ra Medical Systems Announces Results of its Special Meeting of Stockholders and a 1-for-50 Reverse Stock Split

MILWAUKEE , Sept. 14, 2022 /PRNewswire/ -- Ademi LLP is investigating Ra Medical (NYSE American: RMED) for possible breaches of fiduciary duty and other violations of law in its transaction with Catheter Precision.

Shareholder Alert: Ademi LLP investigates whether Ra Medical Systems, Inc.'s transaction with Catheter Precision is fair to shareholders

Wilmington, Delaware--(Newsfile Corp. - September 13, 2022) - Rigrodsky Law, P.A. is investigating Ra Medical Systems, Inc. ("Ra Medical") (NYSE: RMED) regarding possible breaches of fiduciary duties and other violations of law related to Ra Medical's agreement to merge with Catheter Precision, Inc.To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-ra-medical-systems-inc.To contact Seth D. Rigrodsky or Gina M. Serra cost free, call or text (302) 295-5310 or email info@rl-legal.com.Rigrodsky Law, P.A.

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Ra Medical Systems, Inc. Merger

NEW YORK , Sept. 13, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Ra Medical Systems, Inc. ("Ra Medical" or the "Company") (NYSE: RMED) in connection with the proposed merger of the Company with Catheter Precision, Inc. ("Catheter Precision").

SHAREHOLDER ALERT: Weiss Law Investigates Ra Medical Systems, Inc.

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Ra Medical Systems, Inc. (NYSE: RMED) (“the Company”) with Catheter Precision, Inc. pursuant to which Ra Medical shareholders will own approximately 20% of the combined company, on a fully diluted basis calculated using the treasury stock method, subject to certain adjustments. KSF is seeking to determine wh

RA MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Ra Medical Systems, Inc. - RMED

RA Medical Systems (NYSEMKT: RMED ) is rising steadily today on the news of a merger. In a statement released today, the company announced that it has entered into a “definitive merger agreement” with medical technology producer Catheter Precision.

Why Is Ra Medical Systems (RMED) Stock Up 30% Today?

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Ra Medical Systems, Inc. (NYSE: RMED) and Catheter Precision, Inc. is fair to Ra Medical shareholders. Halper Sadeh encourages Ra Medical shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns whether Ra Medical and its boa

News for Ra Medical Systems Inc Stock (RMED)